Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.

Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.

Healing and prevention of relapse of reflux oesophagitis by cisapride.

Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.

High doses of ranitidine in patients with reflux oesophagitis.

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.

The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis.

$Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.$
Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

$Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.$
Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.

Efficacy of misoprostol and ranitidine in the prevention of duodenal ulcer relapse and its correlation with endogenous gastric prostanoid synthesis.

$Treatment of refractory ulcerative oesophagitis with omeprazole.$
Treatment of refractory ulcerative oesophagitis with omeprazole.

Australian clinical trials of omeprazole in the management of reflux oesophagitis.

Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.

Combination therapy of sucralfate and ranitidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis.

Letter: Diagnosis of "reflux oesophagitis".

Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials.

$Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.$
Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Healing and relapse of duodenal ulcer during ranitidine therapy in the elderly. The RUDER Study Group.



Oesophageal motor function before and after healing of oesophagitis.

The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing.

Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.

Alkaline reflux oesophagitis.

Suggest Documents

Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.

Healing and prevention of relapse of reflux oesophagitis by cisapride.

Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.

High doses of ranitidine in patients with reflux oesophagitis.

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.

The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis.

Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.

Efficacy of misoprostol and ranitidine in the prevention of duodenal ulcer relapse and its correlation with endogenous gastric prostanoid synthesis.

Treatment of refractory ulcerative oesophagitis with omeprazole.

Australian clinical trials of omeprazole in the management of reflux oesophagitis.

Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.

Combination therapy of sucralfate and ranitidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis.

Letter: Diagnosis of "reflux oesophagitis".

Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials.

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Healing and relapse of duodenal ulcer during ranitidine therapy in the elderly. The RUDER Study Group.

Letter: Diagnosis of "reflux oesophagitis".

Letter: Diagnosis of "reflux oesophagitis".

Oesophageal motor function before and after healing of oesophagitis.

The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing.

Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.

Alkaline reflux oesophagitis.

Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.

Recommend Documents

Follow Us